Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

94.57
-0.1400-0.15%
Post-market: 94.660.0900+0.10%19:59 EDT
Volume:12.68M
Turnover:1.20B
Market Cap:238.89B
PE:14.03
High:94.88
Open:94.28
Low:93.45
Close:94.71
Loading ...

Europe Approves Merck's Cancer Drug For Two Indications

Benzinga
·
19 Feb

Exclusive-Merck and Plaintiff Suing Over Alleged Gardasil Vaccine Injuries Agree to Delay Trial Until September 2025 With New Jury

THOMSON REUTERS
·
19 Feb

Exclusive-Merck Agrees to Halt Ongoing Trial Over Hpv Vaccine in Los Angeles Superior Court, Company Says

THOMSON REUTERS
·
19 Feb

Exclusive-Merck Vaccine Case With Ties to Hhs Secretary Kennedy Delayed, Company Says

THOMSON REUTERS
·
19 Feb

Merck Gets Conditional Approval in EU for Drug Treating Von Hippel-Lindau Disease

MT Newswires Live
·
19 Feb

UnitedHealth, Sherwin-Williams Co. Share Losses Lead Dow's 131-Point Drop

Dow Jones
·
18 Feb

Merck KGaA to replace two executives with company veterans

Reuters
·
18 Feb

Deutsche Bank Downgrades Merck to Hold From Buy, Cuts Price Target to $105 From $128

MT Newswires Live
·
18 Feb

Merck Cut to Hold From Buy by Deutsche Bank

Dow Jones
·
18 Feb

Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now

Insider Monkey
·
18 Feb

BRIEF-Welireg Receives First European Commission Approval For Two Indications

Reuters
·
18 Feb

Welireg® (Belzutifan) Receives First European Commission Approval for Two Indications

THOMSON REUTERS
·
18 Feb

Deutsche downgrades Merck ahead of Keytruda 2028 expiration

TIPRANKS
·
18 Feb

Irish goods trade surplus with U.S. hit record $52 billion in 2024

Reuters
·
17 Feb

Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?

Insider Monkey
·
17 Feb

Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes

Insider Monkey
·
16 Feb